Q32 Bio, Inc. (QTTB)
8.72
-0.10
(-1.13%)
USD |
NASDAQ |
Nov 13, 16:00
8.72
0.00 (0.00%)
After-Hours: 19:59
Q32 Bio Price to Book Value : 0.9061 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 0.9165 |
| November 11, 2026 | 0.956 |
| November 10, 2026 | 0.9695 |
| November 09, 2026 | 0.9705 |
| November 06, 2026 | 0.9612 |
| November 05, 2026 | 0.9196 |
| November 04, 2026 | 0.9321 |
| November 03, 2026 | 0.9103 |
| November 02, 2026 | 0.9051 |
| October 30, 2026 | 0.9258 |
| October 29, 2026 | 0.9217 |
| October 28, 2026 | 0.9414 |
| October 27, 2026 | 0.9051 |
| October 26, 2026 | 0.878 |
| October 23, 2026 | 0.8988 |
| October 22, 2026 | 0.9144 |
| October 21, 2026 | 0.9009 |
| October 20, 2026 | 0.8957 |
| October 19, 2026 | 0.8095 |
| October 16, 2026 | 0.7814 |
| October 15, 2026 | 0.8074 |
| October 14, 2026 | 0.8323 |
| October 13, 2026 | 0.8375 |
| October 12, 2026 | 0.9082 |
| October 09, 2026 | 0.8666 |
| Date | Value |
|---|---|
| October 08, 2026 | 0.8406 |
| October 07, 2026 | 0.8302 |
| October 06, 2026 | 0.8427 |
| October 05, 2026 | 0.8697 |
| October 02, 2026 | 0.8552 |
| October 01, 2026 | 0.8573 |
| September 30, 2026 | 0.8593 |
| September 29, 2026 | 2.136 |
| September 28, 2026 | 2.069 |
| September 25, 2026 | 1.966 |
| September 24, 2026 | 2.066 |
| September 23, 2026 | 2.143 |
| September 22, 2026 | 2.369 |
| September 21, 2026 | 2.347 |
| September 18, 2026 | 2.362 |
| September 17, 2026 | 2.434 |
| September 16, 2026 | 2.461 |
| September 15, 2026 | 2.504 |
| September 14, 2026 | 2.445 |
| September 11, 2026 | 2.488 |
| September 10, 2026 | 2.403 |
| September 09, 2026 | 2.497 |
| September 08, 2026 | 2.620 |
| September 04, 2026 | 2.687 |
| September 03, 2026 | 2.869 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intellia Therapeutics, Inc. | 2.220 |
| Beam Therapeutics, Inc. | 2.481 |
| Prime Medicine, Inc. | 19.32 |
| Korsana Biosciences, Inc. | 3.673 |
| Prelude Therapeutics, Inc. | 2.058 |
Price to Book Value Related Metrics
| PE Ratio | 2.609 |
| PS Ratio | 3.288 |
| Price | 8.72 |
| Earnings Yield | 38.33% |
| Market Cap | 260.66M |
| Operating PE Ratio | 9.614 |
| Normalized PE Ratio | 2.605 |